Sage Journals: Discover world-class research

Abstract

Background

Diabetic retinopathy (DR) is one of the serious complications of diabetes mellitus. Laser therapy is the traditional treatment for DR, and the role of vitreous injection of ranibizumab in DR requires evaluation. This meta-analysis aimed to compare the efficacy of ranibizumab combined with laser versus laser monotherapy in treating diabetic retinopathy.

Method: We searched PubMed, Scopus, Web of Science, Embase, China Biology Medicine Disc (CBM), China National Knowledge Infrastructure (CNKI), and Wanfang databases, from their inception to October 2024. Randomized controlled trials (RCTs) that compared the effectiveness of ranibizumab combined with laser versus laser monotherapy in the treatment of diabetic retinopathy were searched. We used the Cochrane Collaboration tool to evaluate the risk of bias.

Results

Our analysis included 18 studies. The improvement time for retinal edema in the ranibizumab combined with the laser group was significantly shorter than that in the laser monotherapy group (P < 0.05). The time to absorb fundus hemorrhage in the ranibizumab combined with the laser group was significantly shorter than that in the laser monotherapy group (P < 0.05). The absorption time of fundus exudation in the ranibizumab combined with the laser group was significantly lower than that of the laser monotherapy group (P < 0.05). The rate of improvement in vision in the ranibizumab combined with the laser group was significantly higher than that of the laser monotherapy group (P < 0.05). There were no significant differences in the incidence of adverse reactions (P > 0.05) and retinal thickness in the macula (P > 0.05) between ranibizumab combined with the laser group and the laser monotherapy group.

Conclusion

The combination of ranibizumab and laser for diabetic retinopathy is more effective than laser monotherapy.

Keywords

ranibizumab laser therapy diabetic retinopathy

Get full access to this article

View all access options for this article.

References

Teo

Tham

, et al. Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis. Ophthalmology 2021; 128: 1580–1591.

Xing

. Tangniaobing Zhenzhi Shiyong Zhinan[M]. HeBei: Hebei Science & Technology Press, 2016, p.164.

Resnikoff

Pascolini

Etya’ale

, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004; 82: 844–851.

Tan

Wong

. Diabetic retinopathy: looking forward to 2030[J]. Front Endocrinol (Lausanne) 2023; 13: 1077669.

Wang

Gong

, et al. Study on the effects of different anti-VEGF drugs on fibrovascular membranes of proliferative diabetic retinopathy[J]. Photodiagnosis Photodyn Ther 2023; 42: 103530.

Ferrara

Damico

Shams

, et al. Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration[J]. Retina 2006; 26: 859–870.

Rentiya

Ferraz

Hutnik

, et al. Evaluation of contrast sensitivity in non-high-risk proliferative diabetic retinopathy treated with panretinal photocoagulation with and without intravitreal injections of ranibizumab[J]. Arq Bras Oftalmol 2022; 85: 37–45.

Kumar

Surve

Mondal

, et al. Macular hole formation following panretinal photocoagulation in proliferative diabetic retinopathy[J]. BMJ Case Rep 2021; 14: e240730.

Yin

Zhong

. Efficacy of ranibizumab combined with photocoagulation for diabetic retinopathy: a meta-analysis study. Medicine (Baltimore)[J] 2023; 102: e34170.

10.

Zhong

. Clinical effect of fundus laser combined with ranibizumab in the treatment of diabetic retinopathy[J]. Guide China Med 2023; 21: 55–58.

11.

. Clinical study of fundus laser combined with ranibizumab in the treatment of diabetic retinopathy[J]. China Pract Med 2019; 14: 119–120.

12.

Liu

. Efficacy analysis of fundus laser combined with ranibizumab in the treatment of diabetic retinopathy[J]. Gansu Sci Technol 2018; 34: 129–130.

13.

Zeng

. Clinical efficacy analysis of fundus laser combined with ranibizumab in the treatment of diabetic retinopathy[J]. Diabetes New World 2019; 22: 178–182.

14.

Xie

Cai

Ding

. Study on the clinical value of fundus laser combined with ranibizumab in the treatment of diabetic retinopathy[J]. Diabetes New World 2018; 21: 170–172.

15.

Lin

Zeng

, et al. The effect of fundus laser combined with ranibizumab in the treatment of diabetic retinopathy[J]. China Pract Med 2020; 15: 171–173.

16.

Chen

. Clinical effect observation of fundus laser combined with ranibizumab in the treatment of diabetic retinopathy[J]. J Med Theory Pract 2021; 34: 1497–1499.

17.

Han

. Clinical study and analysis of Fundus Laser combined with ranibizumab in treating diabetic retinopathy[J]. China Med Device Inform 2018; 24: 119–121.

18.

Chen

. Clinical effects of fundus laser combined with ranibizumab treatment in patients with diabetic retinopathy[J]. China Rural Health 2016: 11–12.

19.

Song

Ding

Wang

, et al. The value of fundus laser combined with renizumab in the treatment of diabetic retinopathy[J]. Heilongjiang Med Pharmacy 2019; 42: 70–73.

20.

Fan

. Observations on the therapeutic value of fundus laser and ranibizumab in diabetic retinopathy[J]. Electron J Clin Med Literature 2018; 5: 72–73.

21.

Tang

. Clinical effect and prognosis analysis of treatment of diabetic retinopathy with ranibizumab therapy combined with fundus laser treatment[J]. J Pract Diabetol 2018; 14: 47–48.

22.

Liu

Huang

. Clinical effects of ranibizumab combined with fundus laser in the treatment of diabetic retinopathy[J]. Diabetes New World 2020; 23: 173–177.

23.

Shen

. Analysis of the effect of ranibizumab combined with fundus laser therapy on diabetic retinopathy[J]. Health Essentials 2022: 141–142.

24.

Guo

. Efficacy of rezumab combined with Laser photocoagulation in the treatment of DR[J]. China Health Stand Manag 2020; 11: 97–99.

25.

Huang

Hang

Wang

. Analysis of the effect of Laser therapy + ranibizumab on diabetic retinopathy[J]. China Foreign Med Treatment 2021; 40: 25–27.

26.

Zhao

. Analyzing the clinical effect of fundus laser combined with ranibizumab in the treatment of diabetic retinopathy[J]. Health Essentials 2021: 42–43.

27.

Hao

. Analyzing the clinical efficacy of fundus laser combined with ranibizumab in the treatment of diabetic retinopathy[J]. Smart Healthcare 2018; 4: 112–113.

28.

Berger

Sheidow

Cruess

, et al. Efficacy/safety of ranibizumab monotherapy or with laser versus laser monotherapy in DME[J]. Can J Ophthalmol 2015; 50: 209–216.

29.

Mitchell

Bandello

Schmidt-Erfurth

, et al. The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema[J]. Ophthalmology 2011; 118: 615–625.

30.

Lang

Liakopoulos

Vögeler

, et al. The RELATION study: efficacy and safety of ranibizumab combined with laser photocoagulation treatment versus laser monotherapy in NPDR and PDR patients with diabetic macular oedema[J]. Acta Ophthalmol[J] 2018; 96: e377–e385.

31.

Wong

Sun

Kawasaki

, et al. Guidelines on diabetic eye care: the international council of ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings. Ophthalmology[J] 2018; 125: 1608–1622.

32.

Liu

Song

, et al. Ranibizumab assisted vitreoretinal surgery for the treatment of proliferative diabetic retinopathy[J]. Recent Advances in Ophthalmology 2019; 39: 574–578.

33.

Liu

Xia

Guo

, et al. Effect of fundus retinal argon laser photocoagulation combined with calcium dobesilate in the treatment of diabetic retinopathy[J]. Int Eye Sci 2021; 21: 37–41.

34.

Hui

. Application progress of laser photocoagulation in diabetic retinopathy treatment in the era of anti-vascular endothelial growth factor agents[J]. Int Eye Sci 2023; 23: 1285–1289.

35.

Chen

. Analysis of the clinical value of ranibizumab combined with fundus laser in the treatment of diabetic retinopathy[J]. Moder Med Health Res Electr J 2022; 6: 51–54.

36.

Huang

Cai

, et al. Clinical trial of calcium dobesilate capsules combined with ranibizumab in the treatment of macular edema of diabetic retinopathy[J]. Chinese J Clin Pharmacol 2018; 34: 2707–2710.

37.

Zhou

. Liu ZY.prognosis of VEGF inhibitors combined with laser therapy in patients with diabetic retinopathy[J]. Int Eye Sci 2017; 17: 234–237.

38.

Zou

Ren

, et al. Clinical research on laser therapy and ranibizumab for proliferative diabetic retinopathy[J]. Int Eye Sci 2016; 16: 107–110.

39.

Zeng

. The clinical effect of Fundus Laser combined with rizumab in patients with severe non-proliferative diabetic retinopathy[D]. An Hui: Anhui Medical University, 2022: 27–32.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.24 MB

0.00 MB

Efficacy of ranibizumab with laser in the treatment of diabetic retinopathy compare with laser monotherapy: A systematic review and meta-analysis

Abstract

Background

Results

Conclusion

Keywords

Get full access to this article

References

Supplementary Material